Molecular Classification
B lymphocyte, Immune cell
Disease Roles
AutoimmunityHematologic malignancy

CD20-positive B cell Overview

CD20-positive B cells are a subset of B lymphocytes characterized by the expression of the CD20 surface antigen. They are involved in antibody production, antigen presentation, cytokine secretion, and immune regulation. Aberrant populations or functions of CD20-positive B cells are associated with autoimmune diseases and hematologic malignancies, making them therapeutic targets for monoclonal antibodies like rituximab.

Mechanism of Action

Antibody-dependent cell-mediated cytotoxicity (ADCC), complement-dependent cytotoxicity (CDC), direct apoptosis induction via anti-CD20 antibody binding.

Biological Functions

Antibody production
Antigen presentation
Cytokine secretion
Immune regulation
Maintenance of resting state in mature B lymphocytes
Receptor organization

Disease Associations

Autoimmunity
Hematologic malignancy

Safety Considerations

  • Infusion reactions
  • Tumor lysis syndrome
  • Progressive multifocal leukoencephalopathy (PML)
  • Increased risk of infection

Interacting Drugs

Rituximab

Associated Biomarkers

Biomarker
CD20 expression level for patient selection
B cell counts for monitoring depletion therapy